Two FDA-approved delivery options, guided by your provider
Jose-Cappola then customizes your care using tools like GLP-1 medications (Semaglutide, Tirzepatide) , HCG therapy , nutritional counseling , and metabolic support
Previous work has shown that the abundance of Lactobacillus reuteri (normalized to a control group) decreases during the onset of obesity and remains suppressed even after dieting in mice 99 , which parallels our observations that vehicle-treated diet-switched mice had lower levels of Lactobacillus than the 5A-1MQ-treated mice, the latter of which also demonstrated greater weight loss
5A-1MQ-treated mice switched from WD to LD (WD/LD-T) showed a rather reduced relative abundance of Akkermansia compared to vehicle-treated DIO animals switched from WD to LD (WD/LD-V), suggesting a unique microbiome mechanism associated with weight loss in the vehicle-treated group switched from WD to LD compared to the 5A-1MQ-treated group that underwent the same diet switch
How do I take 5-Amino-1MQ oral or subcutaneous
"Central and Peripheral Molecular Targets for Anti-Obesity Pharmacotherapy"
